KRAS dosage key in PDAC

被引:0
|
作者
Hugh Thomas
机构
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:130 / 130
相关论文
共 50 条
  • [1] KRAS dosage key in PDAC
    Thomas, Hugh
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (03) : 130 - 130
  • [2] KRAS degradation averts PDAC chemoresistance
    Leonhardt, Laura
    Hebrok, Matthias
    NATURE CANCER, 2024, 5 (03) : 375 - 377
  • [3] KRAS degradation averts PDAC chemoresistance
    Laura Leonhardt
    Matthias Hebrok
    Nature Cancer, 2024, 5 : 375 - 377
  • [4] Targeting KRAS in PDAC: A New Way to Cure It?
    He, Qianyu
    Liu, Zuojia
    Wang, Jin
    CANCERS, 2022, 14 (20)
  • [5] Identifying synergistic combinations with KRAS inhibition in PDAC
    Thege, Fredrik I.
    Hoskins, Amber
    Woermann, Sonja M.
    Maitra, Anirban
    CANCER RESEARCH, 2024, 84 (17)
  • [6] Response and resistance to KRAS inhibition in PDAC mouse models
    Abbassi, Laleh
    Dilly, Jullien
    Yang, Annan
    Uribe, Giselle
    Parent, Branden
    Hennessey, Connor
    Kapner, Kevin
    Jordan, Alexander
    Dasgupta, Shatavisha
    Morgado, Micaela
    Baslan, Taimour
    Qiang, Li
    Winter, Peter
    Chugh, Seema
    Shalek, Alex
    Stanger, Ben
    Raghavan, Srivastan
    Lowe, Scott
    Wolpin, Brian
    Dougan, Stephanie
    Nowak, Jonathan
    Aguirre, Andrew
    CANCER RESEARCH, 2024, 84 (02)
  • [7] Targeting KRAS inhibitor resistance by ferroptosis induction in PDAC
    Padhye, Aparna
    Yu, Qijia
    Sindoni, Nicole
    Zhang, Huan
    Dilly, Julien
    Feng, Hanrong
    Aguirre, Andrew
    Mancias, Joseph
    CANCER RESEARCH, 2024, 84 (17)
  • [8] Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Kamgar, Mandana
    George, Ben
    Szabo, Aniko
    Annunzio, Kaitlin
    Taylor, Bradley W.
    Shreenivas, Aditya Varnam
    Chakrabarti, Sakti
    Thomas, James P.
    Tsai, Susan
    Christians, Kathleen K.
    Evans, Douglas B.
    Clarke, Callisia
    Hall, William Adrian
    Erickson, Beth
    Ahmed, Gulrayz
    Thapa, Bicky
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] SOAT1 as a targetable KRAS dependency in PDAC
    Lan, Wenjun
    Sun, Shoujun
    Nigri, Jeremy
    Homer, Josh
    Park, Young
    Deschenes, Astrid
    Cifani, Paolo
    Cross, Justin
    Gaeth, Victoria
    Kim, Sunny
    Ting, Shawn
    Rubino, Rachel
    Moses, John
    Tuveson, David
    CANCER RESEARCH, 2024, 84 (02)